RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:revenueThis is just speculation but they'll have to do an abbreviated Phase 3 (6 months?) plus say another 6-12 months for regulatory approval? Say 12-18 months from the annoucement of a licensing deal to FDA approval? Revenue for Q1 2017? Just a guess. Bilastine will be adding to the bottom line well before Bezalip. (Q1 2016).